Analyst Shen discusses Enphase Energy ( ENPH) Q4:24 results on an Analyst/Indusry conference call to be held on February 5 at 8:45 am. Webcast Link ...
Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, ...
Roth MKM analyst Justin Clare maintained a Buy rating on Atkore International Group (ATKR – Research Report) today and set a price target of ...
We recently compiled a list of the 10 AI News Updates Trending on Wall Street. In this article, we are going to take a look ...
Equities research analysts at Roth Capital cut their Q4 2024 EPS estimates for Viper Energy in a report released on Tuesday, January 28th. Roth Capital analyst L. Mariani now anticipates that the oil ...
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...
Roblox (NYSE:RBLX – Free Report) had its target price lifted by Roth Mkm from $54.00 to $70.00 in a research report report ...
3hon MSN
PLBY Group (PLBY) is jumping 20% today after the company announced that it was converting 25% of its preferred shares to ...
Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...
Roth MKM raised the firm’s price target on Axis Capital (AXS) to $110 from $90 and keeps a Buy rating on the shares. The firm notes that while it was early in calling the re-underwriting change ...
https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 ...
As of December 3, 2024, the average one-year price target for CervoMed is $54.74/share. The forecasts range from a low of $34.34 to a high of $73.50. The average price target represents an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback